224 related articles for article (PubMed ID: 34999833)
21. mTORC1-mediated downregulation of COX2 restrains tumor growth caused by TSC2 deficiency.
Li H; Jin F; Jiang K; Ji S; Wang L; Ni Z; Chen X; Hu Z; Zhang H; Liu Y; Qin Y; Zha X
Oncotarget; 2016 May; 7(19):28435-47. PubMed ID: 27078846
[TBL] [Abstract][Full Text] [Related]
22. A circuitry and biochemical basis for tuberous sclerosis symptoms: from epilepsy to neurocognitive deficits.
Feliciano DM; Lin TV; Hartman NW; Bartley CM; Kubera C; Hsieh L; Lafourcade C; O'Keefe RA; Bordey A
Int J Dev Neurosci; 2013 Nov; 31(7):667-78. PubMed ID: 23485365
[TBL] [Abstract][Full Text] [Related]
23. Tsc1-mTORC1 signaling controls striatal dopamine release and cognitive flexibility.
Kosillo P; Doig NM; Ahmed KM; Agopyan-Miu AHCW; Wong CD; Conyers L; Threlfell S; Magill PJ; Bateup HS
Nat Commun; 2019 Nov; 10(1):5426. PubMed ID: 31780742
[TBL] [Abstract][Full Text] [Related]
24. Mourning Dr. Alfred G. Knudson: the two-hit hypothesis, tumor suppressor genes, and the tuberous sclerosis complex.
Hino O; Kobayashi T
Cancer Sci; 2017 Jan; 108(1):5-11. PubMed ID: 27862655
[TBL] [Abstract][Full Text] [Related]
25. Cell-specific alterations of glutamate receptor expression in tuberous sclerosis complex cortical tubers.
Talos DM; Kwiatkowski DJ; Cordero K; Black PM; Jensen FE
Ann Neurol; 2008 Apr; 63(4):454-65. PubMed ID: 18350576
[TBL] [Abstract][Full Text] [Related]
26. Ornithine decarboxylase, the rate-limiting enzyme of polyamine synthesis, modifies brain pathology in a mouse model of tuberous sclerosis complex.
Kapfhamer D; McKenna J; Yoon CJ; Murray-Stewart T; Casero RA; Gambello MJ
Hum Mol Genet; 2020 Aug; 29(14):2395-2407. PubMed ID: 32588887
[TBL] [Abstract][Full Text] [Related]
27. Neuronal Tsc1/2 complex controls autophagy through AMPK-dependent regulation of ULK1.
Di Nardo A; Wertz MH; Kwiatkowski E; Tsai PT; Leech JD; Greene-Colozzi E; Goto J; Dilsiz P; Talos DM; Clish CB; Kwiatkowski DJ; Sahin M
Hum Mol Genet; 2014 Jul; 23(14):3865-74. PubMed ID: 24599401
[TBL] [Abstract][Full Text] [Related]
28. Tsc2 gene inactivation causes a more severe epilepsy phenotype than Tsc1 inactivation in a mouse model of tuberous sclerosis complex.
Zeng LH; Rensing NR; Zhang B; Gutmann DH; Gambello MJ; Wong M
Hum Mol Genet; 2011 Feb; 20(3):445-54. PubMed ID: 21062901
[TBL] [Abstract][Full Text] [Related]
29. Phenotypic Screen with TSC-Deficient Neurons Reveals Heat-Shock Machinery as a Druggable Pathway for mTORC1 and Reduced Cilia.
Di Nardo A; Lenoël I; Winden KD; Rühmkorf A; Modi ME; Barrett L; Ercan-Herbst E; Venugopal P; Behne R; Lopes CAM; Kleiman RJ; Bettencourt-Dias M; Sahin M
Cell Rep; 2020 Jun; 31(12):107780. PubMed ID: 32579942
[TBL] [Abstract][Full Text] [Related]
30. Complex Neurological Phenotype in Mutant Mice Lacking Tsc2 in Excitatory Neurons of the Developing Forebrain(123).
Crowell B; Lee GH; Nikolaeva I; Dal Pozzo V; D'Arcangelo G
eNeuro; 2015; 2(6):. PubMed ID: 26693177
[TBL] [Abstract][Full Text] [Related]
31. TSC patient-derived isogenic neural progenitor cells reveal altered early neurodevelopmental phenotypes and rapamycin-induced MNK-eIF4E signaling.
Martin P; Wagh V; Reis SA; Erdin S; Beauchamp RL; Shaikh G; Talkowski M; Thiele E; Sheridan SD; Haggarty SJ; Ramesh V
Mol Autism; 2020; 11(1):2. PubMed ID: 31921404
[TBL] [Abstract][Full Text] [Related]
32. The Hippo pathway effectors YAP and TAZ promote cell growth by modulating amino acid signaling to mTORC1.
Hansen CG; Ng YL; Lam WL; Plouffe SW; Guan KL
Cell Res; 2015 Dec; 25(12):1299-313. PubMed ID: 26611634
[TBL] [Abstract][Full Text] [Related]
33. Renal disease in tuberous sclerosis complex: pathogenesis and therapy.
Lam HC; Siroky BJ; Henske EP
Nat Rev Nephrol; 2018 Nov; 14(11):704-716. PubMed ID: 30232410
[TBL] [Abstract][Full Text] [Related]
34. TFEB drives mTORC1 hyperactivation and kidney disease in Tuberous Sclerosis Complex.
Alesi N; Khabibullin D; Rosenthal DM; Akl EW; Cory PM; Alchoueiry M; Salem S; Daou M; Gibbons WF; Chen JA; Zhang L; Filippakis H; Graciotti L; Miceli C; Monfregola J; Vilardo C; Morroni M; Di Malta C; Napolitano G; Ballabio A; Henske EP
Nat Commun; 2024 Jan; 15(1):406. PubMed ID: 38195686
[TBL] [Abstract][Full Text] [Related]
35. TrkB hyperactivity contributes to brain dysconnectivity, epileptogenesis, and anxiety in zebrafish model of Tuberous Sclerosis Complex.
Kedra M; Banasiak K; Kisielewska K; Wolinska-Niziol L; Jaworski J; Zmorzynska J
Proc Natl Acad Sci U S A; 2020 Jan; 117(4):2170-2179. PubMed ID: 31932427
[TBL] [Abstract][Full Text] [Related]
36. Tuberous sclerosis as an underlying basis for infantile spasm.
Yeung RS
Int Rev Neurobiol; 2002; 49():315-32. PubMed ID: 12040899
[TBL] [Abstract][Full Text] [Related]
37. [Tuberous Sclerosis Complex].
Kaneda M
Brain Nerve; 2019 Apr; 71(4):374-379. PubMed ID: 30988224
[TBL] [Abstract][Full Text] [Related]
38. Upregulation of the pathogenic transcription factor SPI1/PU.1 in tuberous sclerosis complex and focal cortical dysplasia by oxidative stress.
Zimmer TS; Korotkov A; Zwakenberg S; Jansen FE; Zwartkruis FJT; Rensing NR; Wong M; Mühlebner A; van Vliet EA; Aronica E; Mills JD
Brain Pathol; 2021 Sep; 31(5):e12949. PubMed ID: 33786950
[TBL] [Abstract][Full Text] [Related]
39. Genetically engineered human cortical spheroid models of tuberous sclerosis.
Blair JD; Hockemeyer D; Bateup HS
Nat Med; 2018 Oct; 24(10):1568-1578. PubMed ID: 30127391
[TBL] [Abstract][Full Text] [Related]
40. Transcriptional co-repressor function of the hippo pathway transducers YAP and TAZ.
Kim M; Kim T; Johnson RL; Lim DS
Cell Rep; 2015 Apr; 11(2):270-82. PubMed ID: 25843714
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
